Patents by Inventor Fabio Mucciardi

Fabio Mucciardi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
    Patent number: 8815511
    Abstract: This invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of 1) identifying whether the human subject is a predicted responder to glatiramer acetate by determining the genotype of the subject at one or more single nucleotide polymorphisms (SNPs) selected from the group consisting of the SNPs in Group 1; and 2) administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the subject only if the subject is identified as a predicted responder to glatiramer acetate.
    Type: Grant
    Filed: October 9, 2012
    Date of Patent: August 26, 2014
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Amir Tchelet, Fabio Mucciardi, Joseph Levy